The Royal Bournemouth Hospital is an acute general hospital in Bournemouth, Dorset, England. It is managed by the University Hospitals Dorset NHS Foundation Trust.

There are 723 beds in Royal Bournemouth Hospital.

During the past decade, Royal Bournemouth Hospital conducted 97 clinical trials. In the 10-year time frame, 97 clinical trials started and 42 clinical trials were completed, i.e. on average, 43.3% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 28 clinical trials were completed. i.e. 93.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal Bournemouth Hospital" #1 sponsor was "The Royal Bournemouth Hospital" with 12 trials, followed by "Boehringer Ingelheim" with 8 trials sponsored, "Celgene" with 8 trials sponsored, "Institute of Cancer Research, United Kingdom" with 8 trials sponsored and "University College, London" with 8 trials sponsored. Other sponsors include 162 different institutions and companies that sponsored additional 115 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Bournemouth Hospital" #1 collaborator was "Cancer Research UK" with 17 trials as a collaborator, "AstraZeneca" with 8 trials as a collaborator, "Bristol-Myers Squibb" with 4 trials as a collaborator, "GlaxoSmithKline" with 4 trials as a collaborator and "Merck Sharp & Dohme LLC" with 4 trials as a collaborator. Other collaborators include 217 different institutions and companies that were collaborators in the rest 185 trials.

According to Clinical.Site data, the most researched conditions in "Royal Bournemouth Hospital" are "Coronary Artery Disease" (12 trials), "Multiple Myeloma" (10 trials), "Atrial Fibrillation" (9 trials), "Breast Cancer" (9 trials) and "Colorectal Cancer" (7 trials). Many other conditions were trialed in "Royal Bournemouth Hospital" in a lesser frequency.

Most popular intervention types in "Royal Bournemouth Hospital" are "Drug" (133 trials), "Procedure" (36 trials), "Device" (35 trials), "Other" (28 trials) and "Biological" (20 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "capecitabine" (8 trials), "Dexamethasone" (7 trials), "Cyclophosphamide" (6 trials) and "Lenalidomide" (6 trials). Other intervention names were less common.

The vast majority of trials in "Royal Bournemouth Hospital" are 193 trials for "All" genders, 11 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are 60 active trials in "Royal Bournemouth Hospital". 3 are not yet recruiting, 27 are recruiting, 28 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 108 completed trials in Royal Bournemouth Hospital, 1 suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Royal Bournemouth Hospital, 2 "Phase 1" clinical trials were conducted, 49 "Phase 2" clinical trials and 83 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 49 trials that are defined as “Not Applicable".